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1.  GENERAL INTRODUCTION 
 
  Treatment resistant depression 
Treatment resistant depression is an important problem in clinical practice. 
Antidepressants are commonly used in the treatment of major depression. A model of stage 
was proposed and differential levels of resistance exist in treatment resistant depression?
(Thase and Rush, 1995). Treatment resistant depression was defined as major depression with 
poor response to two or more adequate trials of different class of antidepressant (Souery et al., 
1999). It is estimated that treatment resistant depression occurs about 30% to 40% of 
depressive episode after adequate treatments with first or second antidepressant therapy, 
respectively in 50% response of HAM-D (Souery et al., 1999). Thus, almost 10% of patients 
with depression cannot attain remission or recovery (HAM-D<7) despite availability of an 
increasing number of antidepressants. 
It was found that a set of 11 relevant clinical variables is associated with treatment 
resistant major depressive disorder (for example, comorbid anxiety disorder and personality 
disorder) (Souery et al., 2007). In addition, it was suggested that extraversion, rumination, and 
external locus of control were differentiating psychological characteristics for chronicity of 
depression (Wiersma et al., 2011).  
 
  Neural mechanism and depression 
It is well documented that smaller hippocampal volumes were found in the patients with 
longer cumulative duration of lifetime depression, total number of recurrent episodes, and 
early age of onset of depression (Sheline et al., 1999). Furthermore, MDD subjects have 
shown abnormally reduced activity in lateral prefrontal cortices during explicit voluntary 
control of emotional experience (Rive et al., 2013). Nucleus accumbens is also noted as a 
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candidate of site for depression (Shirayama and Chaki, 2006). Increased amygdala volume in 
the patients with depression is also noted (Frodl et al., 2002).  
Relationship of the cognitive model of depression was proposed by Beck, and neural 
mechanisms have been elucidated (Disner et al., 2011). For example, it is likely that biased 
attention to negative stimulus is related to increased amygdala and anterior cingulate cortex, 
and to decreased right lateral prefrontal cortex and superior parietal cortex (Disner et al., 
2011). 
 
  Psychological factor (resilience and personality) 
Resilience is as dynamic and adaptive process that subserves maintaining, regaining, or 
homeostasis in conditions. Furthermore, resilience entails a process of sustain-ability that 
prevents or attenuates disturbance of mental health after exposure to sever adversity (Rutten 
et al., 2013). In the psychological factors of resilience, secure attachment, experiencing 
positive emotions, having a purpose in life, cognitive processes, personality traits, and active 
coping mechanism are known to be important (Rutten et al., 2013; Wu et al., 2013). 
Resilience is associated with favorable treatment outcome in patients with depression (Min et 
al., 2012). Depressive disorder was helped by resilience-enhancing intervention (Stallard and 
Buck, 2013). 
Positive emotions are active ingredients within trait resilience, which reduce the risk of 
depression (Fredrickson et al., 2003). Increases in positive emotion during the first week of 
pharmacological treatment in depressed patient predicted improved depression scores and 
recovery from depression 6weeks later (Geschwind et al., 2011). In neuroimaging study, 
positive emotion was found to be related with activity of subgenual cingulated-centered 
limbic cortical network that affect sad mood induction (Keightley et al., 2003).   
Resilience was negatively associated with neuroticism, and positively related to 
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extraversion and conscientiousness, in their relations to personality (Campbell-Sills et al., 
2006). Previous studies reported that depressed patients demonstrate high neuroticism, and 
low extraversion and conscientiousness compared to healthy control. The biological and 
psychological basis of neuroticism was recently reviewed (Ormel et al., 2013). Furthermore, 
neuroticism was quantified by neuroimaging studies (Servaas et al., 2013). In functional 
connectivity of limbic system, it has been revealed that right amygdala-medial prefrontal 
cortex connectivity was positively correlated with neuroticism score in response to negative 
emotional facial expressions (Cremers et al., 2010). For a while, extraversion had positive 
correlations with whole-brain functional networks and a relationship with response in 
somatosensory cortex (Gao et al., 2013; Schaefer et al., 2012). 
There are a variety of ways in which personality features may play a role in development 
and treatment of major depression. There are five etiological models (Vulnerability model, 
Pathoplasty model, Complication model, Spectrum model, Common-Cause model) to account 
for relation between personality and major depression (Bagby et al., 2008a). Many research 
demonstrated that personality features could be useful in diagnosis and treatment (Bagby et 
al., 2008a). For example, neuroticism is associated with negative outcome in general (Mulder, 
2002), whereas extraversion appears to be consistently associated with a more favorable 
outcome to treatment (Bagby et al., 1995). Personality dysfunction is associated with 
impaired short-term response to antidepressant treatment in major depression (Gorwood et al., 
2010) 
In the relationships between personality traits and treatment response, cognitive behavior 
therapy might be superior to interpersonal psychotherapy for depressed patients with high 
harm avoidance (Joyce et al., 2007). Additionally, treatment resistant depressive patients with 
high neuroticism are more likely to respond pharmacotherapy compared to cognitive 
behavioral therapy (Bagby et al., 2008b). The results suggest that treatment response for 
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Figure 1. Structure of Temperament Character Inventory (TCI) 
 
patients with major depression may be optimized if patient personality traits are taken into 
account. 
 
  TCI and NEO in depression  
In many research and clinical situation, Temperament and Character Inventory (TCI), 
and NEO Personality Inventory Revised (NEO) have been used widely as personality 
assessment tool.  
TCI was developed by Cloninger based on seven factor model of personality (Figure 1). 
In TCI, personality is divided into temperament dimension and character dimension. 
Temperament was postulated to be independently heritable, manifest in early life, and 
individual difference in associative learning in response to novelty, danger or punishment, 
and reward. Temperament dimension include novelty seeking, harm avoidance, reward 
dependence and persistence. Character is defined as second domain of personality, which is  
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Figure 2. Structure of NEO Personality Inventory Revised (NEO) 
 
predominantly determined by socialization processes during the life-span. Character 
dimension include self-directedness, cooperativeness and self-transcendence. Previous 
research consistently reported that high levels of harm avoidance and low levels 
self-directedness were consistently found in patients with major depression (Please see the 
text, Chapter I pp.10).  
NEO assesses five domains of personality based on big five model of personality 
structure (Figure 2). The NEO was the end product of many years of factor analytic studies 
that had as their goal to distill personality into a set of valid and reliable dimensions. NEO is 
comprised neuroticism, extraversion, openness, agreeableness and Conscientiousness. 
Previous studies reported high neuroticism, and low extraversion and conscientiousness in 
depressed patients (Please see the text, Chapter II pp.24). 
As mentioned above, it is well established that there exist personality traits of depressed 
patients. However, psychological features of treatment-resistant depressive patients have 
never been reported. The aim of study is to clarify personality bias of patients with 
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treatment-resistant depression. In these studies, we revealed the psychological features of 
treatment resistant depressive patients and remitted depressive patients compared to healthy 
control. We divided this study into two chapters and report them here. 
 
Chapter I: 
We investigated the possibility of personality biases in treatment-resistant patients with 
MDD, using TCI. In addition, internal correlations of TCI were investigated in each group. 
 
Chapter II: 
We investigated the possibility of personality biases in treatment-resistant patients with 
MDD, using NEO Personality Inventory Revised (NEO-PI-R). In addition, internal 
correlations of NEO were investigated in each group. Furthermore, we examined relationships 
between TCI and NEO in treatment-resistant depressive patients. 
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2.  CHAPTER I 
Personality Traits as Risk Factors for Treatment-Resistant Depression 
 
1.  ABSTRUCT 
Background: The clinical outcome of antidepressant treatment in patients with major 
depressive disorder (MDD) is thought to be associated with personality traits. A number of 
studies suggest that depressed patients show high harm avoidance, low self-directedness and 
cooperativeness, as measured on the Temperament and Character Inventory (TCI). However, 
the psychology of these patients is not well documented. 
Methods: Psychological evaluation using Cloninger’s TCI, was performed on 
treatment-resistant MDD patients (n=35), remission MDD patients (n=31), and age- and 
gender-matched healthy controls (n=174). 
Results: Treatment-resistant patients demonstrated high scores for harm avoidance, and low 
scores for reward dependence, self-directedness, and cooperativeness using the TCI, 
compared with healthy controls and remission patients. Interestingly, patients in remission 
continued to show significantly high scores for harm avoidance, but not other traits in the TCI 
compared with controls. Moreover, there was a significant negative correlation between 
reward dependence and harm avoidance in the treatment-resistant depression cohort, which 
was absent in the control and remitted depression groups. 
Conclusions: This study suggests that low reward dependence and to a lesser extent, low 
cooperativeness in the TCI may be risk factors for treatment-resistant depression. 
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2.  INTRODUCTION 
Antidepressants are commonly used in the treatment of major depressive disorder 
(MDD). Between 60 and 70 percent of depressed patients respond to treatment with the first 
prescribed antidepressant at maximal doses for at least 2 months, and 80 to 90 percent of 
these patients respond to the first or second choice prescribed antidepressant. The 5 to 15 
percent of patients who do not respond to treatment are deemed to have treatment-resistant 
depression (Thase and Rush, 1995). It is noteworthy that response is defined as a reduction to 
less than 50 percent in depressive symptoms, but not necessarily recovery. Remission is 
defined as a full recovery, classified as a score of less than 7 on the Hamilton Rating Scale for 
Depression (HAM-D) (Thase and Rush, 1995). In order to study the psychopathological 
aspects of treatment-resistant depression, it is necessary to extract the core features of 
treatment-resistant depression. 
Cloninger and his colleagues developed a dimensional psychosocial model of personality. 
This Temperament and Character Inventory (TCI) defines four dimensions of temperament: 
novelty seeking, harm avoidance, reward dependence, and persistence, and three dimensions 
of character: self-directedness, cooperativeness, and self-transcendence (Cloninger et al., 
1993). Personality is considered to affect the outcome of mood disorder. It is well established 
that depressed patients showed high scores of harm avoidance and that the severity of 
depression correlates positively with harm avoidance scores on the TCI (Mulder et al., 1994; 
Chien and Dunner, 1996; Hansenne et al., 1999; Richter et al., 2000; Hirano et al., 2002; 
Marijnissen et al., 2002; Farmer et al., 2003; Smith et al., 2005; Celikel et al., 2009; 
Spittlehouse et al., 2010; Sasayama et al., 2011). Furthermore, scores in the harm avoidance 
section are altered by depression and antidepressant treatment (Chien and Dunner, 1996; 
Hirano et al., 2002; Marijnissen et al., 2002; Joffe et al., 1993). In a meta-analysis of MDD 
study data, harm avoidance scores showed a clear negative change from baseline to endpoint 
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(Kampman and Poutanen, 2011). Similarly, it is known that depressed patients showed low 
scores of self-directedness and that the severity of depression correlates negatively with 
self-directedness scores on the TCI (Hansenne et al., 1999; Richter et al., 2000; Hirano et al., 
2002; Marijnissen et al., 2002; Farmer et al., 2003; Smith et al., 2005; Celikel et al., 2009; 
Spittlehouse et al., 2010; Sasayama et al., 2011; Svrakic et al., 1993).  
Favorable outcomes after antidepressant treatment are associated with personality score 
changes. Depressive patients with low harm avoidance scores on the TCI tend to have good 
outcomes (Joyce et al., 1994; Kampman et al., 2012). Typical TCI scores indicating a 
favorable outcome, show decreases in harm avoidance and self-transcendence and increases 
in self-directedness and cooperativeness, from baseline to post- treatment values (Corruble et 
al., 2002). Furthermore, the harm avoidance rate in treatment-resistant patients is significantly 
higher than that of the treatment-response group (Kampman et al., 2012; Nelsen and Dunner, 
1995). However, no significant personality changes were observed in patients with poor 
outcome after antidepressant treatment (Corruble et al., 2002). Both non-responders and 
responders showed increased harm avoidance scores, and decreased self-directedness and 
cooperativeness scores on the TCI (Hirano et al., 2002). However, it remains unclear which 
components of personality influence treatment-resistance in MDD patients. 
The purpose of this study was to evaluate the psychological features of 
treatment-resistant patients with MDD. Here, we investigated the possibility of personality 
biases in treatment-resistant patients with MDD, using Cloninger’s seven-factor model, TCI 
(Cloninger et al., 1993). 
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Table 1-1. Demographic information of subjects 
----------------------------------------------------------------------------------------------------------------------- 
                Healthy Remitted Treatment-resistant   p values 
 Control       depression     depression? ? ?
----------------------------------------------------------------------------------------------------------------------- 
Current age (years)     ?  36.76 ± 9.52 (17-60)   40.58 ± 7.88 (28-55)?   38.74 ± 9.42 (22-53)    0.080?  
Sex (male/female)   135/39   18/13?  24/11              0.056 
Age on set? (years)? ? ? ? ?   38.00 ± 8.42 (25-54)   35.94 ± 8.93 (17-50)     0.366 
Duration of depressive state (months)? ? ?   19.04 ± 24.26 (3-49)  36.46 ± 21.32 ** (9-98)       < 0.001 
Duration of treatment (months)            23.31 ± 22.32 (3-103) 30.06 ± 26.23 (4-97)       0.235 
HAM-D                               4.38 ± 1.63 (2-7)   18.31 ± 4.04 **(14-28)        < 0.001 
Trial numbers of antidepressants? ? ?   1.20 ± 0.40 (1-2)      2.60 ± 1.56 **(2-9)          < 0.001 
-----------------------------------------------------------------------------------------------------------------------  
Data are shown as mean ± SD. Parenthesis is the range. 
**p<0.001 as compared to the remitted group (Student’s t-test) 
HAM-D: Hamilton Rating Scale for Depression 
 
3.  METHODS 
  3.1. Ethics Statement 
The study was approved by the ethics committee of Teikyo University Chiba Medical 
Center (study number 09-30) and performed in accordance with the Declaration of Helsinki. 
Written informed consent was obtained from all participants after the procedures had been 
fully explained. 
  3.2. Participants 
 A total of 174 healthy subjects, 35 antidepressant treatment-resistant depressive patients, 
and 31 remitted depressive patients were enrolled in this study (Table 1-1). All patients were 
recruited from the outpatient clinics of Teikyo University Chiba Medical Center (Ichihara, 
Chiba, Japan), and met the DSM-IV criteria for MDD (first episode) (American Psychiatric 
Association, 1994). Two senior-level psychiatrists assessed patients’ psychopathology. 
Patients were all physically healthy and free of alcohol or drug abuse. Inclusion criteria 
required symptoms of moderate depression, after treatment with at least two antidepressants, 
for 8 weeks. Patient scores were 14 or more on the 17-item HAM-D scale, where the 
definition of remission (recovery) was 7 or less (Thase and Rush, 1995). Healthy control 
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subjects with no past history of psychiatric disorders or drug dependence were recruited. 
Clinical information regarding the subjects is provided in Table 1. The duration of depression 
in treatment-resistant patients was significantly longer than in remitted depression (Table 
1-1). 
  3.3. Personality Scores and Psychological Tests 
 Personality was assessed using the TCI-125 (a shortened version of the TCI) (Cloninger 
et al., 1993; Smith et al., 2005; Tome et al., 1997; Black and Sheline, 1997). The Japanese 
version of TCI has been validated and tested for reliability in Japan (Kijima et al., 2005; 
Takeuchi et al., 2011). Items were rated on a four-point scale (1; totally disagree, 2; disagree, 
3; agree and 4; totally agree). This test covers four dimensions of temperament, namely: harm 
avoidance, novelty seeking, reward dependence, and persistence, and three dimensions of 
character: self-directedness, cooperativeness, and self-transcendence. To obtain normative 
data, this test was performed on the 174 healthy controls. 
  3.4. Statistical Analysis 
Data from the seven TCI dimensions were first analyzed using multiple analysis of 
variance (MANOVA), to determine the simultaneous existence of significant differences. 
Statistical differences among the three groups were determined by a one-way factorial 
analysis of variance (ANOVA), followed by a multiple comparison test (Scheffe’s test). 
Chi-square test was used for categorical variables. Statistical evaluation between the two 
groups was performed using a two-tailed Student’s t-test. Coefficients among scores of TCI 
were estimated by Pearson coefficient. Differences were considered to be significant when p 
values were less than 0.01. 
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4.  Results 
MANOVA indicated a significant group effect (F=9.101, p<0.0001). 
Subsequent one-way ANOVA demonstrated that treatment-resistant patients showed 
significantly altered scores on harm avoidance, reward dependence, self-directedness and 
cooperativeness, but not novelty seeking, persistence, or self- transcendence compared with 
remitted depression patients and healthy controls (Figure 1-1). Relative to healthy controls, 
patients in remission only showed significantly increases in scores for harm avoidance 
(Figure 1-1). 
The subscales of each dimension of the TCI are shown in Table 1-2. Treatment-resistant 
patients showed significantly high scores for anticipatory worry, fear of uncertainty and 
fatigability in the harm avoidance, and low scores for attachment in reward dependence, 
responsibility, purposefulness, resourcefulness and congruent second nature in the 
self-directedness, and empathy, helpfulness and pure-heartedness in the cooperativeness 
category, compared to remitted depression patients and healthy controls. 
Interestingly, harm avoidance, self-directedness and self-transcendence correlate 
significantly with HAM-D scores in all MDD patients (harm avoidance, r=0.434, 
p<0.0001; self-directedness, r=0.485, p<0.0001; self-transcendence, r=0.343, p<0.001). 
In contrast, there were no correlations between TCI scores and severity of depression in 
patients with treatment-resistant depression (data not shown). 
There was a significant negative correlation between reward dependence and harm 
avoidance in treatment-resistant depression patients. This correlation was not present in 
healthy controls and remitted depression patients (Table 1-3). Furthermore, there was a 
significant negative relationship between cooperativeness and the dimensions of novelty 
seeking and harm avoidance, in the treatment-resistant group, but not in the healthy control 
and remitted depression groups (Table 1-3). Conversely, there was a significant negative 
 13 
correlation between novelty seeking and harm avoidance scores in the healthy control and 
remitted depression groups, but not in the treatment-resistant depression group (Table 1-3). 
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Figure 1-1. The data of TCI 
Analysis of variance (ANOVA) shows a significant difference between three groups for (B) Harm 
Avoidance (F (2,237)=50.58; p<0.001), (C) Reword Dependence (F (2,237)=13.19; p<0.001), (E) 
Self-Directedness (F (2,237)=25.98; p<0.001), and (F) Cooperativeness (F (2,237)=5.42; p=0.005). There are not 
significant differences between three groups in (A) Novelty seeking, F (2,237)=4.44, p=0.013, (D) Persistence, 
(F (2,237)=1.81, p=0.167, and (G) Self-transcendence, F (2,237)=2.51, p=0.084. *p<0.01, **p<0.001 compared 
to control (ANOVA followed by Scheffe’s test). 
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Table 1-2. Comparison of TCI subscales in subjects 
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------- 
                        Healthy Remitted  Treatment         
                          control  depression resistant  F  p 
                                                     depression 
 (n = 174) (n = 31) (n = 35)  
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------- 
< Novelty seeking >          48.58 ± 6.40     46.65 ± 6.35    45.31 ± 6.37    4.44   0.013 
  Exploratory excitability  12.60 ± 1.96 12.36 ± 2.11 11.49 ± 2.12  4.54   0.012 
  Impulsiveness  12.43 ± 2.26 11.65 ± 2.32 10.69 ± 2.78**  8.66   < 0.001 
  Extravagance  12.68 ± 2.81 12.45 ± 2.40 12.71 ± 2.86  0.09    0.916 
  Disorderliness  10.78 ± 2.22 10.19 ± 2.65 10.23 ± 1.82  1.58     0.208 
< Harm avoidance >          49.62 ± 8.15   55.65 ± 9.16**   64.59 ± 7.81**, ##  50.58   < 0.001 
  Anticipatory worry  11.79 ± 2.39 13.17 ± 2.40 16.03 ± 2.07**, ## 48.70   < 0.001 
  Fear of uncertainty  13.98 ± 2.34 14.78 ± 2.94 16.67 ± 2.17**, # 18.65   < 0.001 
  Shyness  11.97 ± 2.96     13.45 ± 2.95 14.97 ± 3.11** 16.25   < 0.001 
  Fatigability  11.92 ± 2.60 14.26 ± 2.61** 16.94 ± 2.24**, ## 61.32   < 0.001 
< Reward dependence > 43.82 ± 5.35   43.00 ± 3.51   38.60 ± 7.36**, #  13.19  < 0.001 
  Sentimentality           ?   14.23 ± 2.17   14.32 ± 2.24 13.00 ± 2.99  4.36    0.014 
  Attachment  14.39 ± 2.67 14.07 ± 2.00 11.29 ± 3.55**, ## 18.64   < 0.001  
  Dependence  15.17 ± 2.26  14.61 ± 1.63 14.34 ± 2.95  2.31    0.102 
< Persistence > 13.83 ± 2.20   14.07 ± 2.79   13.06 ± 2.98    1.81   0.167 
< Self-directedness > 70.16 ± 8.64   69.03 ± 7.06   58.28 ± 11.51**, ## 25.98 < 0.001           
  Responsibility  15.79 ± 2.41  13.25 ± 2.98 13.26 ± 2.98** 16.60   < 0.001  
  Purposefulness  14.34 ± 1.93  14.03 ± 2.09 11.14 ± 2.84**, ## 33.81   < 0.001 
  Resourcefulness  14.21 ± 2.07  13.42 ± 2.55 11.14 ± 2.57**, ## 28.14   < 0.001 
  Self-acceptance  11.91 ± 3.46 12.90 ± 3.24 11.17 ± 3.86  2.03     0.134 
  Congruent second nature    13.83 ± 2.00     14.00 ± 1.97   11.51 ± 2.23**, ##  19.93   < 0.001 
< Cooperativeness >  75.33 ± 8.03 74.10 ± 7.81   70.37 ± 9.07*  5.42  0.005 
  Social acceptance      15.83 ± 2.33     15.00 ± 2.56      14.66 ± 2.29? ? ?   4.56    0.011 
  Empathy                   13.22 ± 1.87  12.90 ± 2.21 11.97 ± 2.27*  5.84    0.003  
  Helpfulness  15.23 ± 2.07 14.74 ± 2.00       13.37 ± 2.77** 10.66   < 0.001  
  Compassion              15.11 ± 2.73  16.07 ± 2.63 15.66 ± 2.63  1.96     0.143 
  Pure-heartedness  15.95 ± 1.93  15.39 ± 2.00 14.77 ± 2.39*  5.42     0.005  
< Self-transcendence > 28.18 ± 6.38 29.61 ± 7.49 25.80 ± 5.65  3.09  0.047 
  Self-forgetfulness   8.62 ± 2.59  9.23 ± 2.68  8.20 ± 2.69  1.28     0.279 
  Transpersonal identification  10.03 ± 2.41  10.29 ± 2.82  8.80 ± 2.11  4.23    0.017 
  Spiritual acceptance    9.65 ± 2.42  10.07 ± 2.63  8.89 ± 2.35  2.59     0.125 
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------- 
Data are shown as mean ± SD. 
*p<0.01, **p<0.001 compared to control (ANOVA followed by Scheffe’s test).  
#p<0.01, ##p<0.001 compared to remitted depression (ANOVA followed by Scheffe’s test) 
 16 
Table 1-3. Correlates of TCI variables  
--------------------------------------------------------------------------------------------------------------------------------------------------------------------   
Healthy control (n=174) NS HA  RD  P  SD  C ST  
--------------------------------------------------------------------------------------------------------------------------------------------------------------------   
Novelty seeking (NS)               !       
Harm avoidance (HA)          -.463**  !      
Reward dependence (RD) .063- .115  !     
Persistence (P) -.018- .146 .109  !    
Self-directedness (SD) -.142  -.399** .232* .093  !   
Cooperativeness (C) -.093 -.169 .639** .177 .358**  !  
Self-transcendence (ST) .194 -.043 .007 .148 -.308** .041  ! 
---------------------------------------------------------------------------------------------------------------------------------------------------------------------  
---------------------------------------------------------------------------------------------------------------------------------------------------------------------  
Remitted depression (n=31)    NS HA  RD  P  SD  C ST  
---------------------------------------------------------------------------------------------------------------------------------------------------------------------  
Novelty seeking (NS)  !       
Harm avoidance (HA) -.525*  !      
Reward dependence (RD) .376 -.173  !     
Persistence (P) .287 -.401 .252  !    
Self-directedness (SD) .292 -.334 .466* .027  !   
Cooperativeness (C) .071 -.055 .486* -.069 .396  !  
Self-transcendence (ST) .438 -.288 .383 .263 .105 .314  ! 
----------------------------------------------------------------------------------------------------------------------------------------------------------------------   
----------------------------------------------------------------------------------------------------------------------------------------------------------------------   
Treatment-resistant    NS HA  RD  P  SD  C ST  
depression ( n=35) 
----------------------------------------------------------------------------------------------------------------------------------------------------------------------   
Novelty seeking (NS)  !       
Harm avoidance (HA) .034  !      
Reward dependence (RD) -.074 -.466*  !     
Persistence (P) -.246 -.366 .330  !    
Self-directedness (SD) -.407 -.603** .512* .290  !   
Cooperativeness (C) -.437* -.519* .599** .368 .577**  !  
Self-transcendence (ST) .377 -.121 .119 .295 -.023 .121  ! 
----------------------------------------------------------------------------------------------------------------------------------------------------------------------    
*p<0.01, **p<0.001 
 
 
5.  Discussion 
 In this study, we found a number of psychological features that appeared to be 
associated with treatment-resistant MDD. Firstly, we found treatment-resistant patients 
showed higher scores for harm avoidance and lower scores for self-directedness on the TCI, 
consistent with previous reports on depressed patients (Hansenne et al., Richter et al., 2000; 
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Table 1-4. Summary of TCI scores of depressed patients  
----------------------------------------------------------------------------------------------------------------------------------------------------------- 
                                  NS      HA      RD      P       SD      C       ST 
-----------------------------------------------------------------------------------------------------------------------------------------------------------   
Hansenne et al., 1999 [5]    ! " ! ! # # " 
Richiter et al., 2000 [6]     #? ?   "   !?  #?  #?  !? ?  ! 
Farmer et al., 2003 [9]     #? ?  "?  !? ?   !? ?  #?  #? ?  ! 
Smith et al., 2005 [10]        !? ? ?  "?  !?  !? ? ?  #?  !? ?  ! 
Celikel et al., 2009 [11]      ! " !?  !? ? ?  #?  !? ?  ! 
Sasayama et al., 2011 [13]    "?  " !?  !? ? ?  #?  #? ? ?  ! 
Kampman et al., 2012 [18]     !? ?  "? ?  "?  !?   !? ?   !? ? ?  ! 
This study (treatment-resistant)  ! "     # !     #    #     ! 
----------------------------------------------------------------------------------------------------------------------------------------------------------- 
NS: Novelty seeking, HA: Harm avoidance, RD: Reward dependence, P: Persistence,  
SD: Self-directedness, C: Cooperativeness, ST: Self-transcendence 
?: Increase, ?: Decrease, ?: No change 
 
Farmer et al., 2003; Smith et al., 2005; Celikel et al., 2009; Sasayama et al., 2011). We also 
found that harm avoidance and self-directedness correlate significantly with HAM-D scores 
in both remitted and treatment-resistant patients with depression, replicating previous studies 
(Richter et al., 2000; Hirano et al., 2002; Celikel et al., 2009; Spittlehouse et al., 2010). Of the 
seven published studies on TCI scores in depression (Table 1-4), all found significant 
alterations in the score for harm avoidance and all but one in the score for self-directedness, 
indicating that this is a common pattern in depression. Since treatment-resistant patients suffer 
from depressive symptoms, it is not surprising that these non-responders showed the same 
pattern of high harm avoidance and low self-directedness as depressed patients. 
 Secondly, treatment-resistant patients demonstrated low scores for reward dependence 
on the TCI. To the best of our knowledge, this is the first report showing this feature in 
treatment-resistant MDD patients, and there are no equivalent reports in depressed patients 
groups (Table 1-4). This is suggestive of low reward dependence being a characteristic feature 
of treatment-resistant MDD. Looking more closely at reward dependence, the subscale altered 
between remitted patients and healthy controls is attachment. Thus, it is likely that the 
dimension of attachment in reward dependence could be specific to treatment-resistant 
patients. In a recent study of the antidepressant treatment responders, scores for reward 
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dependence had a small overall positive change from baseline to endpoint (Kampman and 
Poutanen, 2011). This is supportive of other studies where depressive patients showing high 
reward dependence on the TCI, also showed a good outcome after antidepressant treatment 
(Joyce et al., 1994; Tome et al., 1997). Interestingly, scores for reward dependence in 
non-depressive siblings of depressed patients, were significantly higher than for siblings with 
a history of depression, suggesting that high reward dependence may protect against the 
development of depression (Farmer et al., 2003). However, it is unknown whether the 
enduring characteristics of non-responders are primary or secondary to the disease. A long 
history of treatment-resistant depression may induce character changes within patients and 
these changes may persist after the recovery from disease. Future studies will be needed to 
elucidate these points. 
 Thirdly, treatment-resistant patients showed low scores for cooperativeness. Significant 
scores for low cooperativeness in depressed patients were reported in three of the seven 
studies examining this issue (Table 1-4) (Hansenne et al., 1999, Farmer et al., 2003; 
Sasayama et al., 2011). This lower concordance suggests that low cooperativeness is a less 
common characteristic of depressed patients compared with high harm avoidance and low 
self-directedness. Within the subscale of cooperativeness, the most significantly altered 
dimensions in comparison with healthy controls, were empathy, helpfulness and 
pure-heartedness. These results should prove useful in tailoring psychotherapy for MDD 
treatment-resistant patients. The cooperativeness score correlated negatively with the severity 
of depression among depressive patients (Hansenne et al., 1999). Other studies showed large 
increases in cooperativeness and self-directedness scores among treatment responders in 
MDD, with relative stability of these features among non-responders during treatment 
(Hirano et al., 2002; Corruble et al., 2002; Black and Sheline, 1997). A recent study 
demonstrated that cooperativeness was strongly associated with perceived social support 
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(Cloninger et al., 2011). As mentioned before, it remains unknown whether low 
cooperativeness is related primarily to treatment-resistant depression or is a secondary effect 
due to the long duration of illness. Previous studies using TCI showed that low scores for 
cooperativeness and self-directedness strongly predicted personality disorders in patients with 
mood disorders (Svrakic et al., 1993; Black and Sheline, 1997). Furthermore, low 
cooperativeness could be a predictor for hostility and paranoia (Conrad et al., 2009). Low 
reward dependence is strongly associated with cluster A symptoms, such as paranoid, 
schizoid and schizotypal personality disorders (Svrakic et al., 1993). It is well known that 
personality disorders have negative effects on the course and outcome of MDD (Mulder, 
2002; Gorwood et al., 2010; Skodol et al., 2011). Therefore, treatment-resistant patients with 
MDD may suffer from some underlying personality disorder traits, although patients with 
overt personality disorders were excluded from this study at recruitment. 
 Fourthly, our results showed significant negative correlations between reward 
dependence and harm avoidance and between cooperativeness and novelty seeking in the 
treatment-resistant depression group, which were absent in healthy controls and remitted 
depression patients. This newly highlighted relationship in treatment-resistant depression 
patients indicates that low scores for reward dependence and cooperativeness could at least in 
part be due to harm avoidance and novelty seeking, respectively. 
 Finally, patients in remission still showed high scores for harm avoidance, compared 
with normal controls, although the difference was small. In this case, the altered subscale 
between remitted patients and controls was fatigability. This finding is supported by a 
previous study demonstrating that even though a significant reduction occurred, higher harm 
avoidance among unipolar depression patients persisted after treatment, compared with 
healthy controls (Richter et al., 2000). Future studies will be needed to elucidate whether 
harm avoidance plays a role in the relapse of depression. 
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 In conclusion, treatment-resistant patients with MDD demonstrated high scores for 
harm avoidance, and low scores for reward dependence, self-directedness, and 
cooperativeness, using the TCI. It is well known that depressed patients show high harm 
avoidance and low self-directedness, and sometimes low cooperativeness on the TCI. Patients 
with treatment-resistant MDD show persistent symptoms of depression. Our findings suggest 
that low reward dependence and to a lesser extent, cooperativeness on the TCI may constitute 
possible risk factors of treatment-resistant depression. 
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   3.  CHAPTER II 
   Low Openness on the Revised NEO Personality Inventory as a Risk Factor for   
   Treatment-Resistant Depression 
 
1.  ABSTRACT 
Background: Recently, we reported that low reward dependence, and to a lesser extent, low 
cooperativeness in the Temperature and Character Inventory (TCI) may be risk factors for 
treatment-resistant depression. Here, we analyzed additional psychological traits in these 
patients. 
Methods: We administered Costa and McCrae’s five-factor model personality inventory, 
NEO Personality Inventory-Revised (NEO-PI-R), to antidepressant-treatment resistant 
depressed patients (n=35), remitted depressed patients (n=27), and healthy controls (n=66). 
We also evaluated the relationships between scores on NEO and TCI, using the same cohort 
of patients with treatment-resistant depression, as our previous study. 
Results: Patients with treatment-resistant depression showed high scores for neuroticism, low 
scores for extraversion, openness and conscientiousness, without changes in agreeableness, on 
the NEO. However, patients in remitted depression showed no significant scores on NEO. 
Patients with treatment-resistant depression and low openness on NEO showed positive 
relationships with reward dependence and cooperativeness on the TCI. 
Conclusions: Many studies have reported that depressed patients show high neuroticism, low 
extraversion and low conscientiousness on the NEO. Our study highlights low openness on 
the NEO, as a risk mediator in treatment-resistant depression. This newly identified trait 
should be included as a risk factor in treatment-resistant depression. 
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2.  INTRODUCTION 
 It is well documented that 60 to 70 percent of depressed patients respond to first line 
antidepressant treatment at maximum dose, for at least two months. Between 80 and 90 
percent of these patients respond to first or second choice prescribed antidepressant 
medication. The remaining 10 to 15 percent of patients who do not respond to therapy are 
deemed to have treatment-resistant depression (Thase and Rush, 1995; Souery et al., 2007). 
Response is defined as a reduction in depressive symptoms to less than 50 percent, but not 
necessarily recovery. Remission is described as a full recovery. We recently reported that low 
reward dependence and to a lesser extent, low cooperativeness in the Temperature and 
Character Inventory (TCI) may be risk factors for treatment-resistant depression (Cloninger et 
al., 1993). Furthermore, patients with remitted depression show high scores for harm 
avoidance, relative to healthy controls (Takahashi et al., 2013). It is likely that additional 
psychological factors associated with depression are yet to be identified from this group of 
patients. 
 Another personality inventory, the NEO Personality Inventory-Revised (NEO-PI-R) is 
also in common use (Costa et al., 2005). This five-factor model of personality structures 
personality in terms of five traits: neuroticism, extraversion, openness, agreeableness, and 
conscientiousness. Numerous studies have reported that depressed patients show high scores 
for neuroticism and low scores for extraversion and conscientiousness using the NEO (Bagby 
et al., 1998; Enns et al., 2000; Petersen et al., 2001; Du et al., 2002; Duberstein and Heisel, 
2007; Chopra et al., 2005; Tang et al., 2009; Rector et al., 2012). The severity of depression 
correlates positively with neuroticism and negatively with extraversion (Du et al., 2002; 
Duberstein and Heisel, 2007; Bagby et al., 1995; Griens et al., 2002). The personality traits of 
neuroticism and extraversion are associated with negative and positive emotional experiences, 
respectively (McCrae and Costa, 2003). Furthermore, neuroticism scores differed between the 
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depressed and post antidepressant treatment states (Du et al., 2002; Griens et al., 2002; Costa 
et al., 2005; Quilty et al., 2008). 
 Chronically depressed patients also reported higher levels of neuroticism and lower 
levels of extraversion, agreeableness, and conscientiousness, compared with those suffering 
acute forms of the disease (Wiersma et al., 2011). Treatment-resistant depression patients had 
significantly higher neuroticism and lower extraversion scores (Bagby et al., 1995). 
Interestingly, the duration of depressive episodes significantly correlates with high levels of 
premorbid neuroticism (Scott et al., 1995). Scores of neuroticism increased, while scores of 
extraversion and conscientiousness decreased with the occurrence of depression, but the 
scores for conscientiousness changed very little on recovery from depressive disorders 
(Karsten et al., 2012). At times, individuals with remitted depression showed significantly 
more neuroticism than healthy controls (Elliott et al., 2012). It is well known that residual 
symptoms during remission have a strong prognostic value (Fava et al., 2007). These results 
indicate that some psychological features are resistant to treatment and persistent in patients 
with remitted depression. 
 The purpose of this study was to investigate in more depth, the presence of personality 
biases in patients with treatment-resistant depression, using the NEO-PI-R (Costa and 
McCrae, 1997). Additionally, we evaluated the relationships between scores obtained using 
NEO in this study, and those obtained using TCI in our previous study (Takahashi et al., 
2013), using the same cohort of treatment-resistant depression patients. 
 
3.  Methods 
  3.1. Ethics statement 
 The study was approved by the ethics committee of Teikyo University Chiba Medical 
Center (study number 09-30) and performed in accordance with the Declaration of Helsinki. 
 24 
Written informed consent was obtained from all participants, after procedures had been fully 
explained. 
  3.2. Subjects 
 Sixty six healthy subjects, 27 depressed patients in remission, and 35 antidepressant 
treatment-resistant depressed patients were enrolled on this study (Table 2-1). The 
treatment-resistant depressed patients were the same sample used in our previous study 
(Takahashi et al., 2013). All patients met the DSM-IV criteria for major depressive disorder 
(MDD) (first episode) (American Psychiatric Association, 1994). Patients were recruited from 
the outpatient clinics of Teikyo University Chiba Medical Center. All patients were physically 
healthy and free of alcohol or drug abuse. Inclusion criteria required symptoms of moderate 
depression, after treatment with at least two antidepressants, for 8 weeks (Souery et al., 2007). 
Scores for patients were 14 or more on the 17-item Hamilton Rating Scale for Depression 
(HAM-D), on which remission or recovery was scored at 7 or less (Thase and Rush, 1995). 
Healthy control subjects with no past history of psychiatric disorders or drug dependence 
were recruited. Clinical information on all subjects is provided in Table 2-1. The duration of 
depressive states in patients with treatment-resistant depression was significantly longer than 
in those with remitted depression. 
  
Table 2-1. Demographic information of subjects 
---------------------------------------------------------------------------------------------------------------------------------------------- 
                       ? ? ?  Healthy     Remitted       treatment-resistant p values 
                           control     depression      depression 
---------------------------------------------------------------------------------------------------------------------------------------------- 
Current age (years)        38.09 ± 8.46 (23-61)  39.07 ± 9.19 (22-56)    38.74 ± 9.42 (22-53) 0.821 
Sex (male/female)   56/10   18/9      24/11  0.073 
Age on set? (years)? ? ? ? ? ? ? ?      36.07 ± 9.27 (22-54)    35.94 ± 8.93 (17-50) 0.955 
Duration of depressive state (months)? ? ?  19.44 ± 15.67 (3-68)   36.46 ± 21.32* (9-98) 0.002 
Duration of treatment (months)                         26.63 ± 24.34 (6-54)   30.06 ± 26.23 (4-97) 0.517 
HAM-D                               4.48 ± 2.76 (3-7)? ?  18.31 ± 4.04 ** (14-28) < 0.001 
Trial numbers of antidepressants? ? ?   1.26 ± 0.45 (1-2)? ? ?    2.54 ± 1.25 ** (2-9) < 0.001 
-----------------------------------------------------------------------------------------------------------------------------------------------  
Data are shown as mean ± SD. Parenthesis is the range. 
**p<0.001 as compared to the remitted group (Student’s t-test) 
 HAM-D: Hamilton Rating Scale for Depression 
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  3.3. Personality Scores and Psychological Tests 
 Personality was assessed using NEO PI-R. NEO PI-R utilized the five-factor model of 
personality: neuroticism, extraversion, openness, agreeableness, and conscientiousness (Costa  
and McCrae, 1997). Each domain scale is comprised of six item facets. The NEO-PI-R 
consists of 240 items answered on a five- point Likert scale, ranging from absolutely disagree 
to strongly agree. Raw scores were converted to T-scores for standardization. The mean and 
SD for each dimension are 50 and 10, respectively. 
 TCI Scores in patients with treatment-resistant depression were taken from our recently 
reported study. In this study, we used TCI-125, a shortened version of the TCI (Cloninger et 
al., 1993; Kijima et al., 2000; Takeuchi et al., 2011). Items are rated on a four-point scale. 
This test covers four dimensions of temperament: harm avoidance, novelty seeking, reward 
dependence, and persistence, and three dimensions of character: self-directedness, 
cooperativeness, and self-transcendence. 
  3.4. Statistical Analysis 
 Data from five domains of the NEO were first analyzed using multiple analysis of 
variance (MANOVA), to check for the simultaneous existence of significant differences. 
Statistical differences among the three groups were determined by one-way factorial analysis 
of variance (ANOVA), followed by multiple comparison testing (Scheffe’s test). Chi-square 
test was used for categorical variables. Statistical evaluation between the two groups was 
performed using a two-tailed Student’s t-test. Coefficients among scores for NEO and TCI 
were estimated by Pearson coefficient. Differences were considered to be significant when p 
values were less than 0.01. 
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4.  Results 
  4.1. Psychological Features assessed by NEO 
 MANOVA indicated a significant group effect  (F=5.777, p<0.0001). Subsequent 
one-way ANOVA demonstrated that patients with treatment-resistant depression showed 
significantly high scores for neuroticism and lower scores for extraversion, openness and 
conscientiousness on the NEO, compared with healthy controls or patients with remitted 
depression (Figure 2-1). Patients in remission showed no significant differences in NEO 
scores, compared to healthy controls (Figure 2-1). 
 The subscales of each domain on the NEO are shown in Table 2-2. Patients with 
treatment-resistant depression showed significantly higher scores for anxiety, depression, 
self-consciousness and vulnerability in the neuroticism subset. They also showed low scores 
for warmth, gregariousness, assertiveness, activity, excitement-seeking, and positive emotion 
in the extraversion subset, feelings and actions in the openness subset, modesty in the 
agreeableness subset, and competent, achievement striving and self-discipline in the 
conscientiousness subset, compared with remitted depression and healthy control subjects 
(Table 2-2). 
 Neuroticism correlated significantly with HAM-D scores in all MDD patients including 
both remitted and treatment-resistant groups (neuroticism, r=0.341, p<0.01; extraversion,  
r=0.497, p<0.001). In contrast, there was no correlation between NEO scores and the severity 
of depression in patients with treatment- resistant depression (data not shown). 
 A significant negative correlation between neuroticism and extraversion was seen in 
healthy controls and remitted depression patients, but not in treatment-resistant depression 
patients (Table 2-3). Significant positive correlation between extraversion and openness was 
seen in healthy controls, but not in the remitted depression and treatment-resistant depression 
groups (Table 2-3). 
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Figure 2-1.  
Analysis of variance shows a significant difference between three groups for (A) Neuroticism (F (2,125)=11.10; 
p<0.001), (B) Extraversion (F (2,125)=26.42; p<0.001), (C) Openness (F (2,125)=5.93; p=0.004), and (E) 
Conscientiousness (F (2,125)=4.88; p=0.009). In (D) Agreeableness, there is not a significant difference between 
three groups (F (2,125)=0.49; p=0.616). *p<0.01, **p<0.001 compared to control (ANOVA followed by Scheffe 
test). 
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Table 2-2. Comparison of NEO subscales in subjects 
------------------------------------------------------------------------------------------------------------------------------------------------------------------------ 
 Healthy Remitted  Treatment-resistant F       p 
                         control      depression    depression 
 (n=66) (n=27) (n=35)  
------------------------------------------------------------------------------------------------------------------------------------------------------------------------ 
< Neuroticism >          50.82 ± 10.55   55.44 ± 9.04   60.94 ± 10.83**   11.10 < 0.001 
  Anxiety 51.24 ± 10.88 56.11 ± 9.72 60.57 ± 9.89**  9.50  < 0.001 
  Angry Hostility 50.62 ± 12.16 53.93 ± 8.10 55.63 ± 11.98  2.42    0.094  
  Depression 50.79 ± 10.49 55.93 ± 10.27 62.57 ± 10.12** 14.96   < 0.001 
  Self-consciousness  50.42 ± 10.48 51.85 ± 8.97 58.00 ± 10.75*  6.38      0.002 
  Impulsiveness  51.88 ± 10.16 53.07 ± 7.34 51.03 ± 12.34  0.30    0.741 
  Vulnerability  49.53 ± 10.65 55.22 ± 10.53 62.11 ± 11.07** 15.86     < 0.001  
< Extraversion >            53.26 ± 10.85?  47.48 ± 9.66   37.00 ± 11.16**  26.42   < 0.001 
  Warmth  52.79 ± 11.75 49.00 ± 8.79 41.09 ± 12.84** 11.81     < 0.001  
  Gregariousness  52.33 ± 12.54 47.44 ± 10.67 40.89 ± 10.71** 11.04     < 0.001  
  Assertiveness  50.62 ± 11.16     48.30 ± 11.18 41.43 ± 10.34**  8.13     < 0.005 
  Activity  52.00 ± 10.79 50.59 ± 9.07 40.46 ± 11.65**, # 13.92     < 0.001 
  Excitement-Seeking         54.86 ± 11.65     46.00 ± 10.41* 42.31 ± 10.52** 16.38    < 0.001 
  Positive Emotions 52.65 ± 11.10 48.48 ± 10.54 39.31 ± 9.48**, # 18.24     < 0.001  
< Openness > 50.76 ± 9.01   50.33 ± 6.90 44.60 ± 9.83*  5.93  0.004 
  Fantasy  48.71 ± 8.46 50.00 ± 8.55 48.09 ± 10.36  0.35      0.706  
  Aesthetics 46.85 ± 10.69 49.26 ± 9.28 43.29 ± 9.41  2.83      0.063  
  Feelings  52.82 ± 9.71      52.15 ± 9.38 46.27 ± 9.34*  5.66      0.004 
  Actions  54.03 ± 10.65 50.00 ± 10.36 46.11 ± 9.47*  6.95      0.001 
  Ideas 49.91 ± 9.95 49.33 ± 8.43 44.31 ± 11.23  3.76      0.026  
  Values  53.26 ± 8.03 54.15 ± 9.21 51.26 ± 10.21  0.91      0.405  
< Agreeableness > 47.71 ± 10.77 49.96 ± 11.02 47.54 ± 10.83  0.48  0.973 
  Trust 51.29 ± 11.70  47.63 ± 10.23 44.14 ± 12.15  4.50      0.013  
  Straightforwardness  46.58 ± 10.31  50.41 ± 9.10 49.20 ± 6.77  2.00      0.140 
  Altruism  48.77 ± 10.57  48.82 ± 9.28 43.74 ± 10.25  3.09      0.049 
  Compliance  49.58 ± 10.51 50.74 ± 10.65 49.17 ± 11.89  0.17      0.134 
  Modesty     46.55 ± 10.44     51.63 ± 12.45   56.23 ± 10.70**   9.20    < 0.001 
  Tender-Mindedness   48.05 ± 10.52  49.44 ± 11.69 48.03 ± 12.03  0.17      0.846 
< Conscientiousness >  50.47 ± 9.94 49.63 ± 11.82 43.54 ± 11.82*  4.88  0.009 
  Competent 51.23 ± 10.78 49.15 ± 11.04 41.94 ± 12.65**  7.32  < 0.001 
  Order 51.71 ± 9.45 51.92 ± 10.07 50.91 ± 12.14  0.09      0.913 
  Dutifulness 47.96 ± 9.28 49.07 ± 9.20 43.86 ± 9.29  3.03    0.052 
  Achievement Striving  52.96 ± 10.87 48.48 ± 10.69 40.06 ± 12.73** 14.71     < 0.001 
  Self-Discipline  50.82 ± 10.21 50.07 ± 13.83 41.37 ± 10.99**  8.58     < 0.001 
  Deliberation  48.15 ± 9.94 48.89 ± 9.77 52.23 ± 10.98  1.87      0.158 
--------------------------------------------------------------------------------------------------------------------------------------- 
Data are shown as mean ± SD. 
*p<0.01, **p<0.001 compared to control (ANOVA followed by Scheffe test).  
#p<0.01, ##p<0.001 compared to remitted depression (ANOVA followed by Scheffe test) 
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Table 2-3. Correlates of NEO factors  
-------------------------------------------------------------------------------------------------------------------------------------- 
Healthy control (n=66)  N E  O  A  Co 
-------------------------------------------------------------------------------------------------------------------------------------- 
Neuroticisms (N)  !   
Extraversion (E) -.395**  !  
Openness (O) .001 .457**  !  
Agreeableness (A) -.346* .277 .265  !  
Conscientiousness (Co) .489** .304 .125  .022  ! 
------------------------------------------------------------------------------------------------------------------------- 
------------------------------------------------------------------------------------------------------------------------- 
Remitted depression (n=27) N E  O  A  Co 
------------------------------------------------------------------------------------------------------------------------- 
Neuroticisms (N)  !  
Extraversion (E) -.610**  !  
Openness (O) .122 .136  !  
Agreeableness (A) .201 -.188 .291  !  
Conscientiousness (Co) -.543* .088 -.126  -.246  !  
-------------------------------------------------------------------------------------------------------------------------- 
-------------------------------------------------------------------------------------------------------------------------- 
Treatment-resistant  N E  O  A  Co 
depression (n=35) 
-------------------------------------------------------------------------------------------------------------------------- 
Neuroticisms (N)  !  
Extraversion (E) -.239  ! 
Openness (O) .026 .411  !   
Agreeableness (A) -.469* .142 .376  !  
Conscientiousness (Co) -.670** .369 -.037  .167  !  
-------------------------------------------------------------------------------------------------------------------------- 
*p<0.01, **p<0.001 
 
  4.2. Relationship between scores on the NEO and the TCI in Patients with  
      Treatment-Resistant Depression 
 As shown in Table 2-4, there were significant, strong relationships between NEO and 
TCI factors, in the patients with treatment-resistant depression. Openness on NEO correlated 
positively with reward dependence and cooperativeness in TCI. Similarly, agreeableness on 
the NEO correlated positively with reward dependence and cooperativeness on TCI. 
Neuroticism on the NEO showed positive correlation with harm avoidance and negative 
correlation with self-directedness and cooperativeness on the TCI. Extraversion on the NEO 
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 *p<0.01, ** p<0.001
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correlated negatively with harm avoidance and positively with reward dependence and 
persistence on the TCI. Conscientiousness on the NEO showed negative correlation with 
harm avoidance and positive correlation with persistence and self-directedness on the TCI. 
 
5.  Discussion 
 We found that patients with treatment-resistant depression showed significantly altered 
scores in neuroticism, extraversion, openness and conscientiousness, as measured by NEO. 
Previous studies using the NEO show that depressed patients scored highly for neuroticism, 
low extraversion and low conscientiousness (Bagby et al., 1998; Petersen et al., 2001; Du et 
al., 2002; Chopra et al., 2005; Rector et al., 2012; Griens et al., 2002). Of the six published 
studies using this scale in depression (Table 2-5), all found significant alterations in scores for 
extraversion and conscientiousness, and all but one found significant changes in scores for 
neuroticism, highlighting a common pattern in depression. Since treatment-resistant patients 
suffer from depressive symptoms, it is not surprising that non-responders showed the same 
pattern of high scores for neuroticism and low scores for extraversion and conscientiousness, 
as depressed patients. It is also highly likely that the remaining factor, low openness, could be 
specific to patients with treatment-resistant depression. Examining the finding for openness, 
the subscales scores altered are feelings and actions (Table 2-2). Thus, it is likely that altered 
feelings and actions could be specific to treatment-resistant patients. It should be noted that 
low openness was associated with high ratios of self-reported, to observer-rated mood 
symptoms (Duberstein and Heisel, 2007). Although only one of six published studies detected 
low openness in depressed patients (Table 2-5) (Griens et al., 2002), the subjects in Griens’s 
study seemed to involve patients with chronic or repetitive episodes of depression, based on 
the recorded long mean duration of illness (over 6 years), the repeated depressive episodes, 
but without high neuroticism. 
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Table 2-5. The published data of NEO scores of depressed patients  
--------------------------------------------------------------------------------------------------------------------------------------  
 N E O  A  C 
--------------------------------------------------------------------------------------------------------------------------------------                                      
Bagby et al., 1998    ! " # # " 
Petersen et al., 2001      ! " # # " 
Du et al., 2001     ! " # # " 
Griens et al., 2002        # " " # " 
Chopra et al., 2005     ! " # # " 
Rector et al., 2012   ! " # # " 
This study (treatment-resistant) ! " " # " 
------------------------------------------------------------------------------------------------------------------------------------- 
N: Neuroticism, E: Extraversion, O: Openness, A: Agreeableness, C: Conscientiousness 
?: Increase, ?: Decrease, ?: No change 
 
 We also detected a significant negative correlation between neuroticism and 
extraversion, in the healthy control and remitted depression groups, but not in the 
treatment-resistant depression group (Table 2-3). This negative relationship was also detected 
in depressed patients, in a previous study (Duberstein and Heisel, 2007). The absence of a 
relationship between neuroticism and extraversion in treatment-resistant depression may 
indicate that these patients have lost an adaptive mechanism that still functions in healthy 
controls. We speculate that neuroticism and extraversion on the NEO are probably less 
dependent on each other than originally thought in treatment-resistant depression. 
Furthermore, it appears that neuroticism and extraversion act together with cooperativeness 
and reward dependence, respectively (Table 2-4), when assessing treatment-resistant 
depression using TCI, as our previous study reported that both reward dependence and 
cooperativeness may be risk factors for treatment-resistant depression (Takahashi et al., 
2013). 
 Patients with treatment-resistant depression showed a negative relationship between 
neuroticism and agreeableness, which also was seen in healthy controls, but not in remitted 
depressed patients (Table 2-3) or in depressed patients examined in different study 
(Duberstein and Heisel, 2007). We put forward that there may be a new connection between 
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neuroticism and agreeableness, rather than between neuroticism and extraversion, leading to 
psychosocial isolation. These connected characteristics may partially contribute to the 
psychological features of treatment-resistant depression. Future studies will be needed to 
elucidate the roles of extraversion and agreeableness in the depressive state. 
 Here, openness on the NEO showed a positive relationship with reward dependence and 
cooperativeness on the TCI, in the treatment-resistant depression group (Table 2-4). Again, it 
should be noted that low scores for reward dependence and cooperativeness on the TCI are 
characteristic features in patients with treatment-resistant depression (Takahashi et al., 2013). 
A previous study showed that openness on the NEO has significant relationships with novelty 
seeking, harm avoidance and self-transcendence on the TCI, in healthy volunteers (De Fruyt 
et al., 2000). Therefore, the remaining relationships between openness on the NEO and 
reward dependence, and cooperativeness on the TCI indicate that these factors may act 
together in treatment-resistant depression. Agreeableness on the NEO also showed a similar 
pattern for reward dependence and cooperativeness on the TCI, and with openness on the 
NEO, in treatment-resistant depression, although agreeableness on the NEO did not reach 
statistically significant levels in this study. A recent study reported that agreeableness on the 
NEO did not show a significant relationship with reward dependence on the TCI in healthy 
controls (De Fruyt et al., 2000). Therefore, agreeableness, as well as openness might play a 
role in the pathology of treatment-resistant depression. 
 We also found significant relationships between neuroticism on the NEO and harm 
avoidance and self-directedness on the TCI in treatment-resistant depression. Additionally, we 
detected association between extraversion on the NEO, and harm avoidance and reward 
dependence on the TCI, and between conscientiousness on the NEO and harm avoidance, 
persistence and self-directedness on the TCI in the same group of patients (Table 2-4). These 
same patterns were also seen in the healthy controls of a previous study (De Fruyt et al., 
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2000), indicating that these characteristics are common to both groups. It is likely that this 
pattern represents the norm and is therefore seen in patients and normal controls. By contrast, 
significant relationships between neuroticism on the NEO and cooperativeness on the TCI, 
and between extraversion on the NEO and persistence on the TCI, were seen only in 
treatment-resistant depression. In addition, these patterns were not seen in healthy volunteers 
of the previously mentioned study (De Fruyt et al., 2000). These newly detected relationships 
in treatment-resistant depression patients indicate that high neuroticism and low extraversion 
on the NEO interact with low cooperativeness and persistence on the TCI, respectively, in the 
pathology of treatment-resistant depression. However, it remains unknown whether 
personality bias occurs as a result of long illness or exists as a cause of treatment-resistance. 
 Finally, this study failed to show any significant factors in remitted depression patients, 
using the NEO (Figure 2-1). However, our previous study using the TCI revealed that 
remitted patients still showed high scores for harm avoidance on the TCI, compared with 
normal controls (Takahashi et al., 2013). Another study using the Maudsley Personality 
Inventory showed that personality traits do not change after a typical episode of major 
depression (Shea et al., 1996). Future studies will be needed to examine the psychological 
factors which contribute to the relapse of depression. 
 We put forward that patients with treatment-resistant depression display lower levels of 
resilience, compared with healthy subjects and remitted depression patients. A previous study 
showed that resilient individuals exhibit lower levels of denial, avoidant coping, pessimism 
and behavioral disengagement (Alimi et al., 2008). Positive emotions, which are generally 
seldom seen in depression, promote adaptive coping, openness to social support and flexible 
thinking (Ong et al., 2006). Negative, rather than positive, life events predict a longer time to 
remission of depression, however, personality traits do not influence the effect of life events 
on disease course indicators (Spinghoven et al., 2011). Social support and educational levels 
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were associated with long-term outcome of treatment-resistant depression (Fekadu et al., 
2012). Furthermore, personality dysfunction was also associated with poor response to 
antidepressant treatment in major depression (Gorwood et al., 2010). Future studies are 
required to aid identification of factors related to resilience in treatment-resistant depression. 
 In conclusion, patients with treatment-resistant depression demonstrated high scores for 
neuroticism, low scores for extraversion, openness and conscientiousness using the NEO. 
Previous studies report that depressed patients show high neuroticism, low extraversion and 
low conscientiousness on the NEO. This would strongly imply that the remaining factor, 
namely, low openness is a specific feature of treatment-resistant depression. Openness on the 
NEO has positive relationships with reward dependence and cooperativeness on the TCI, in 
treatment-resistant depression. Our results indicate that these three factors are important 
mediators in treatment-resistant depression. 
 
 
5.  CONCLUSION 
 In conclusion, patients with treatment-resistant depression demonstrated high harm 
avoidance (TCI) and neuroticism (NEO), and low self-directedness (TCI), reward dependence 
(TCI), cooperativeness (TCI), extraversion (NEO) and conscientiousness (TCI). Previous 
studies report that depressive patients show high harm avoidance and neuroticism, and low 
self-directedness, extraversion and conscientiousness. These results suggest low levels of 
reward dependence (TCI), cooperativeness (TCI) and openness (NEO) may risk factors for 
treatment-resistant depression. Furthermore, positive relationships between Openness (NEO) 
and, reward dependence (TCI) and cooperativeness (TCI) may act together in 
treatment-resistant mechanism of depression.  
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